Partial left ventriculectomy: the 2nd International Registry Report 2000.
BACKGROUND
Partial left ventriculectomy (PLV) has been performed without standardized inclusion or exclusion criteria.


METHODS
An international registry of PLV was expanded, updated, and refined to include 287 nonischemic cases voluntarily reported from 48 hospitals in 11 countries.


RESULTS
Gender, age, ventricular dimension, etiology, ethnology, myocardial mass, operative variation, presence or absence of mitral regurgitation, and transplant indication had no effects on event-free survival, which was defined as absence of death or ventricular failure that required a ventricular assist device or listing for transplantation. Preoperative patient conditions, such as duration of symptoms (> 9 vs < 3 years; p = 0.001), New York Heart Association (NYHA) class (Class IV vs < Class IV; p = 0.002), depressed contractility (fractional shortening [FS] < 5% vs > 12%; p = 0.001), and refractory decompensation that required emergency procedure (p < 0.001) were associated with reduced event-free survival. Five or more cases in each hospital led to significantly better outcomes than the initial four cases. Rescue procedures for 14 patients nonsignificantly improved patient survival (2-year survival 52%) over event-free survival (2-year survival 48%; p = 0.49), with improved NYHA class among survivors (3.6 to 1.8; p < 0.001). Outcome was better in 1999 than in all series before 1999 (p = 0.02) most likely due to patient selection, which was refined to avoid known risk factors such as reduced proportion of patients in NYHA Class IV, FS < 5%, and hospitals with experience in 10 or less cases. A combination of these risk factors could have stratified 17 high-risk patients with 0% 1-year survival and 26 low-risk patients with 75% 2-year event-free survival.


CONCLUSIONS
Avoidance of risk factors appears to improve survival and might help stratify high- or low-risk patients. Although less symptomatic patients with preserved contractility had better results after PLV, change of indication requires prospective randomized comparison with medical therapies or other approaches.
Kawaguchi
A T
AT
Tokai University School of Medicine, Ishara, Kanagawa, Japan. akira@is.icc.u-tokai.ac.jp
Suma
H
H
Konertz
W
W
Popovic
Z
Z
Dowling
R D
RD
Kitamura
S
S
Bergsland
J
J
Linde
L M
LM
Koide
S
S
Batista
R J
RJ
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D000368:Aged; D006348:Cardiac Surgical Procedures / Q000379:methods / Q000401:mortality; D002311:Cardiomyopathy, Dilated / Q000601:surgery; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D006333:Heart Failure / Q000601:surgery; D006352:Heart Ventricles / Q000601:surgery*; D006801:Humans; D007223:Infant; D007391:International Cooperation; D008297:Male; D008875:Middle Aged; D018579:Patient Selection; D012042:Registries / Q000706:statistics & numerical data*; D012307:Risk Factors; D013997:Time Factors